Accepted at 1:04 a.m. Nov, 01, 2023 by dollajas
Author: Ahmed7
Related Note: 1500236922530 1
Rationale for change

imgur: https://imgur.com/a/8e9JT3i

AMBOSS states drug of choice is: IV caspofungin or micafungin (echinocandins) for 2 weeks after resolution of symptoms and documented clearance of C. albicans (alternative is fluconazole and amphotericin B only indicated if there is intolerance, limited availability, or resistance to alternatives) (not sure if we need to include route of administration as well (IV))

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Dermatology::02_Infectious_Diseases_of_the_Skin::04_Candida #AK_Step1_v12::#Pixorize::04_Microbiology::09_Fungi::07_Candida_albicans #AK_Step1_v12::#NinjaNerd::03_Microbiology::04_Pharmacology::02_Antifungals #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#AMBOSS::dRaoN4 #AK_Step1_v12::#FirstAid::03_Microbiology::03_Mycology::02_Opportunistic_fungal_infections::01_Candida_albicans #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step3_v12::#UWorld::5943 #AK_Step1_v12::#FirstAid::03_Microbiology::03_Mycology::02_Opportunistic_fungal_infections #AK_Step1_v12::#B&B::14_Infectious_Disease::04_Fungi::04_Antifungal_Drugs::Extra #AK_Step1_v12::#Bootcamp::Microbiology::37_Antifungals::03_Allylamines,_Echinocandins,_and_Polyenes #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::05_Antifungals::01_Amphotericin_&_Flucytosine #AK_Step1_v12::#Bootcamp::Microbiology::18_Opportunistic_Mycosis::05_Candida_Diagnostics_and_Management #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::01_General_Conditions::02_Neutropenic_Fever_SOAP #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::Retired_Lessons::04_HIV_&_AIDS::02_AIDS_SOAP_[OLD_VERSION] #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#Physeo::06_Micro::03_Fungi::08_Candida_Albicans #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_4::Fungi::Fungi #AK_Step1_v12::#Bootcamp::Microbiology::37_Antifungals::05_Common_Fungal_Disease_Management #AK_Step1_v12::#SketchyMicro::02_Fungi::03_Opportunistic_Fungal_Infections::01_Candida_albicans #AK_Step2_v12::#B&B::08_Infectious_Disease::02_Fungi_&_Parasites::02_Antifungal_Drugs #AK_Step1_v12::#Physeo::09_Pharm::04_Antifungals::04_Echinocandins